France experts opposed to use hydroxychloroquine in Covid-19 patients
Paris, (Prensa Latina) French health authorities on Tuesday took a stand against the use of hydroxychloroquine in patients, after a study suggested its ineffectiveness in combating Covid-19 with additional risks.
The High Council of Public Health recommended in a statement that the controversial antimalarial chloroquine and its derivative should not be used in the treatment of people attacked by the coronavirus SARS-CoV-2, except for clinical trials.
At the same time, the National Drug Safety Agency (NDSA) activated a procedure to suspend 'as a precaution' the incorporation of new patients to those tests aimed at looking for effective drugs against Covid-19.
On Friday, the British medical journal The Lancet published research showing the ineffectiveness of hydroxychloroquine and attributing to it an increased risk of death for Covid-19 patients and the risk of cardiac arrhythmia.
As a result of the study, French Health Minister Olivier Véran ordered the High Council of Public Health to immediately review the prescription of the product to patients, which had been authorized in March.
|By the minute||Most read|